Literature DB >> 15980156

Can a GDP-liganded G-protein be active?

Thomas Wieland1, Martin C Michel.   

Abstract

The replacement of GDP bound to the alpha-subunit of a G-protein by GTP is generally considered a crucial step in the activation of effectors by a G-protein. New data by Uğur et al. (2005) (p. 720) raise the possibility that for the heterotrimeric G-protein Gs, GDP-liganded Gs is able to activate the effector adenylyl cyclase as potently and effectively as when Gs is in its GTP bound form. We summarize here the evidence that GTP is necessary for effector activation by G-proteins and discuss potential implications and limitations of data to the contrary.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15980156     DOI: 10.1124/mol.105.016071

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  4 in total

Review 1.  Interaction of nucleoside diphosphate kinase B with heterotrimeric G protein betagamma dimers: consequences on G protein activation and stability.

Authors:  Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-03       Impact factor: 3.000

2.  Nucleotide exchange-dependent and nucleotide exchange-independent functions of plant heterotrimeric GTP-binding proteins.

Authors:  Natsumi Maruta; Yuri Trusov; David Chakravorty; Daisuke Urano; Sarah M Assmann; Jose R Botella
Journal:  Sci Signal       Date:  2019-11-05       Impact factor: 8.192

Review 3.  Regulation of heterotrimeric G-protein signaling by NDPK/NME proteins and caveolins: an update.

Authors:  Issam H Abu-Taha; Jordi Heijman; Yuxi Feng; Christiane Vettel; Dobromir Dobrev; Thomas Wieland
Journal:  Lab Invest       Date:  2017-10-16       Impact factor: 5.662

Review 4.  High energy phosphate transfer by NDPK B/Gbetagammacomplexes--an alternative signaling pathway involved in the regulation of basal cAMP production.

Authors:  Hans-Joerg Hippe; Thomas Wieland
Journal:  J Bioenerg Biomembr       Date:  2006-08       Impact factor: 3.853

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.